 |
PDBsum entry 3mhc
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Carbonic anhydrase inhibitors. The X-Ray crystal structure of human isoform ii in adduct with an adamantyl analogue of acetazolamide resides in a less utilized binding pocket than most hydrophobic inhibitors.
|
 |
|
Authors
|
 |
B.S.Avvaru,
J.M.Wagner,
A.Maresca,
A.Scozzafava,
A.H.Robbins,
C.T.Supuran,
R.Mckenna.
|
 |
|
Ref.
|
 |
Bioorg Med Chem Lett, 2010,
20,
4376-4381.
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
We investigated the inhibitory activity of several
1,3,4-thiadiazole-sulfonamides against all catalytically active CA (EC 4.2.1.1),
CA I-XV. The tail derivatizing the 5-position in the
1,3,4-thiadiazole-2-sulfonamide scaffold was observed to be critical as an
inhibitory determinant of these compounds. The high resolution X-ray crystal
structure of hCA II in complex with
5-(1-adamantylcarboxamido)-1,3,4-thiadiazole-2-sulfonamide, showed the adamantyl
moiety of the inhibitor residing in a less utilized binding pocket than that of
most hydrophobic inhibitors, lined by the amino acid residues Ile91, Val121 and
Phe131. This binding site may explain the diverse inhibition profiles of
5-carboxamide- and sufonamide-derivatized 1,3,4-thiadiazole-2-sulfonamides and
offers a hot spot for designing isoform selective inhibitors, considering that
residues 91 and 131 are highly variable among the 13 catalytically active
isoforms.
|
 |
|
|
|
|
 |